{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T01:16:15Z","timestamp":1774055775913,"version":"3.50.1"},"reference-count":43,"publisher":"American Association for Cancer Research (AACR)","issue":"7","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Clinical criteria, primarily young age of cancer onset and family history of signature cancers, have been developed to identify individuals at elevated risk for Lynch syndrome with the goals of early identification and cancer prevention. In 2007, the Society of Gynecologic Oncology (SGO)\u2013codified criteria for women presenting with gynecologic cancers. These criteria have not been validated in a population-based setting. For 412 unselected endometrial cancers, immunohistochemical expression of DNA mismatch repair proteins and MLH1 methylation were assessed to classify tumors as sporadic or probable Lynch syndrome (PLS). In this cohort, 10.5% of patients were designated as PLS based on tumor testing. The sensitivity and specificity of the SGO criteria to identify these same cases were 32.6% [95% confidence interval (CI), 19.2\u201348.5] and 77% (95% CI, 72.7\u201381.8), respectively. With the exception of tumor location in the lower uterine segment, multivariate analysis of clinical features, family history, and pathologic variables failed to identify significant differences between the sporadic and PLS groups. A simplified cost-effectiveness analysis demonstrated that the SGO clinical criteria and universal tissue testing strategies had comparable costs per patient with PLS identified. In conclusion, the SGO criteria successfully identify PLS cases among women with endometrial cancer who are young or have significant family history of signature tumors. However, a larger proportion of patients with PLS who are older and have less significant family history are not detected by this screening strategy. Universal tissue testing may be necessary to capture more individuals at risk for having Lynch syndrome. Cancer Prev Res; 7(7); 686\u201397. \u00a92014 AACR.<\/jats:p>","DOI":"10.1158\/1940-6207.capr-13-0359","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T23:42:58Z","timestamp":1398469378000},"page":"686-697","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Evaluation of Clinical Criteria for the Identification of Lynch Syndrome among Unselected Patients with Endometrial Cancer"],"prefix":"10.1158","volume":"7","author":[{"given":"Amanda S.","family":"Bruegl","sequence":"first","affiliation":[{"name":"Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana","family":"Djordjevic","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Laboratory Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Batte","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly","family":"Daniels","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan","family":"Fellman","sequence":"additional","affiliation":[{"name":"2Biostatistics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Urbauer","sequence":"additional","affiliation":[{"name":"2Biostatistics,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajyalakshmi","family":"Luthra","sequence":"additional","affiliation":[{"name":"3Hematopathology, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Sun","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[{"name":"Authors' Affiliations: Departments of 1Gynecologic Oncology and Reproductive Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell R.","family":"Broaddus","sequence":"additional","affiliation":[{"name":"4Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"key":"2022060816262373600_bib1","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/GRF.0b013e3182185a41","article-title":"Lynch syndrome","volume":"54","author":"Backes","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"2022060816262373600_bib2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2022060816262373600_bib3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1053\/j.gastro.2009.07.039","article-title":"Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome","volume":"137","author":"Stoffel","year":"2009","journal-title":"Gastroenterology"},{"key":"2022060816262373600_bib4","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/1097-0142(197710)40:4+<1849::AID-CNCR2820400813>3.0.CO;2-U","article-title":"Role of heredity in multiple primary cancer","volume":"40","author":"Lynch","year":"1977","journal-title":"Cancer"},{"key":"2022060816262373600_bib5","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMoa053493","article-title":"Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer","volume":"354","author":"Barnetson","year":"2006","journal-title":"N Engl J Med"},{"key":"2022060816262373600_bib6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.296.12.1479","article-title":"Prediction of germline mutations and cancer risk in the Lynch syndrome","volume":"296","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"2022060816262373600_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/j.gastro.2010.08.021","article-title":"The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history","volume":"140","author":"Kastrinos","year":"2011","journal-title":"Gastroenterology"},{"key":"2022060816262373600_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/gim.2012.18","article-title":"Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases","volume":"14","author":"Mercado","year":"2012","journal-title":"Genet Med"},{"key":"2022060816262373600_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"2022060816262373600_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.26323","article-title":"Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries","volume":"118","author":"Ryan","year":"2012","journal-title":"Cancer"},{"key":"2022060816262373600_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","article-title":"Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry","volume":"10","author":"Shia","year":"2008","journal-title":"J Mol Diagn"},{"key":"2022060816262373600_bib12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","article-title":"Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives","volume":"11","author":"Berg","year":"2009","journal-title":"Genet Med"},{"key":"2022060816262373600_bib13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.soc.2009.08.001","article-title":"Genetic testing for hereditary colorectal cancer","volume":"18","author":"Hampel","year":"2009","journal-title":"Surg Oncol Clin N Am"},{"key":"2022060816262373600_bib14","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1089\/jwh.2010.2529","article-title":"Trends in endometrial cancer incidence rates in the United States, 1999\u20132006","volume":"20","author":"Duong","year":"2011","journal-title":"J Womens Health"},{"key":"2022060816262373600_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/1940-6207.CAPR-11-0288","article-title":"Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing","volume":"5","author":"Bartley","year":"2012","journal-title":"Cancer Prev Res"},{"key":"2022060816262373600_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/8.4.661","article-title":"MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers","volume":"8","author":"Simpkins","year":"1999","journal-title":"Hum Mol Genet"},{"key":"2022060816262373600_bib17","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa043146","article-title":"Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)","volume":"352","author":"Hampel","year":"2005","journal-title":"N Engl J Med"},{"key":"2022060816262373600_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1053\/j.gastro.2008.04.026","article-title":"The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations","volume":"135","author":"Senter","year":"2008","journal-title":"Gastroenterology"},{"key":"2022060816262373600_bib19","author":"Services CfMaM"},{"key":"2022060816262373600_bib20","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","article-title":"Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome","volume":"26","author":"Westin","year":"2008","journal-title":"J Clin Oncol"},{"key":"2022060816262373600_bib21","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1200\/JCO.2007.10.8597","article-title":"Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer","volume":"25","author":"Lu","year":"2007","journal-title":"J Clin Oncol"},{"key":"2022060816262373600_bib22","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2006.09.019","article-title":"Body mass index: relationship to clinical, pathologic, and features of microsatellite instability in endometrial cancer","volume":"104","author":"McCourt","year":"2007","journal-title":"Gynecol Oncol"},{"key":"2022060816262373600_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2005.06.029","article-title":"Endometrial cancer in young, normal-weight women","volume":"99","author":"Schmeler","year":"2005","journal-title":"Gynecol Oncol"},{"key":"2022060816262373600_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2004.03.068","article-title":"Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance","volume":"127","author":"Hendriks","year":"2004","journal-title":"Gastroenterology"},{"key":"2022060816262373600_bib25","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1086\/421332","article-title":"Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history","volume":"74","author":"Buttin","year":"2004","journal-title":"Am J Hum Genet"},{"key":"2022060816262373600_bib26","first-page":"5068","article-title":"Germ-line msh6 mutations in colorectal cancer families","volume":"59","author":"Kolodner","year":"1999","journal-title":"Cancer Res"},{"key":"2022060816262373600_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/GIM.0b013e31818fa2db","article-title":"EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome","volume":"11","author":"Palomaki","year":"2009","journal-title":"Genet Med"},{"key":"2022060816262373600_bib28","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/archinte.1913.00070050063006","article-title":"Heredity with reference to carcinoma\u2014as shown by the study of the cases examined in the Pathological Laboratory of the University of Michigan, 1895\u20131913","volume":"12","author":"Warthin","year":"1913","journal-title":"Arch Intern Med"},{"key":"2022060816262373600_bib29","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"2022060816262373600_bib30","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1007\/s10552-009-9416-x","article-title":"Genetic variants in the cell-cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome","volume":"20","author":"Chen","year":"2009","journal-title":"Cancer Causes Control"},{"key":"2022060816262373600_bib31","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1158\/1078-0432.CCR-07-1849","article-title":"Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients","volume":"14","author":"Walsh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2022060816262373600_bib32","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ygyno.2009.05.026","article-title":"Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer","volume":"114","author":"Backes","year":"2009","journal-title":"Gynecol Oncol"},{"key":"2022060816262373600_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ygyno.2012.01.049","article-title":"Prospective evaluation of molecular screening for Lynch syndrome in patients with endometrial cancer &lt;\/ = 70 years","volume":"125","author":"Leenen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"2022060816262373600_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1053\/j.gastro.2013.01.044","article-title":"Risk of cancer in cases of suspected lynch syndrome without germline mutation","volume":"144","author":"Rodriguez-Soler","year":"2013","journal-title":"Gastroenterology"},{"key":"2022060816262373600_bib35","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1200\/JCO.2010.32.9979","article-title":"Testing women with endometrial cancer to detect Lynch syndrome","volume":"29","author":"Kwon","year":"2011","journal-title":"J Clin Oncol"},{"key":"2022060816262373600_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1158\/1940-6207.CAPR-10-0262","article-title":"Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population","volume":"4","author":"Dinh","year":"2011","journal-title":"Cancer Prev Res"},{"key":"2022060816262373600_bib37","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/S0002-9440(10)61144-3","article-title":"Endometrial and colorectal tumors from patients with hereditary nonpolyposis colon cancer display different patterns of microsatellite instability","volume":"160","author":"Kuismanen","year":"2002","journal-title":"Am J Pathol"},{"key":"2022060816262373600_bib38","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/302612","article-title":"Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations","volume":"65","author":"Wu","year":"1999","journal-title":"Am J Hum Genet"},{"key":"2022060816262373600_bib39","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"2022060816262373600_bib40","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/PAS.0b013e3181b15aa2","article-title":"Immunohistochemistry as first-line screening for detecting colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: a 2-antibody panel may be as predictive as a 4-antibody panel","volume":"33","author":"Shia","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"2022060816262373600_bib41","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1542-3565(04)00352-0","article-title":"Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients","volume":"2","author":"Grover","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022060816262373600_bib42","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/AOG.0b013e3181da08d7","article-title":"Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities","volume":"115","author":"Meyer","year":"2010","journal-title":"Obstet Gynecol"},{"key":"2022060816262373600_bib43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2011.09.002","article-title":"Endometrial cancer patients and compliance with genetic counseling: room for improvement","volume":"123","author":"Backes","year":"2011","journal-title":"Gynecol Oncol"}],"container-title":["Cancer Prevention Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/7\/686\/2254057\/686.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article-pdf\/7\/7\/686\/2254057\/686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T14:37:00Z","timestamp":1654699020000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerpreventionresearch\/article\/7\/7\/686\/50362\/Evaluation-of-Clinical-Criteria-for-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,1]]},"published-print":{"date-parts":[[2014,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/1940-6207.capr-13-0359","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/1940-6207.22525386.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544725.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22525389.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22525389","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.c.6544725","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/1940-6207.22525386","asserted-by":"object"}]},"ISSN":["1940-6207","1940-6215"],"issn-type":[{"value":"1940-6207","type":"print"},{"value":"1940-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}